Activation of DNA damage response pathways during lytic replication of KSHV

Viruses

Volumn 7, Issue 6, 2015, Pages 2908-2927

  Hollingworth, Robert ^a   Skalka, George L ^a   Stewart, Grant S ^a   Hislop, Andrew D ^a   Blackbourn, David J ^b   Grand, Roger J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

ATM; ATR; DDR; DNA damage response; DNA PK; Kaposi s sarcoma associated herpesvirus; KSHV; Lytic replication

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; CHECKPOINT KINASE 1; DNA DEPENDENT PROTEIN KINASE; DOXYCYCLINE; GANCICLOVIR; HISTONE H2AX; MRE11 PROTEIN; NU 7441; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VE 821; ATM PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; CIB1 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA SYNTHESIS; DOUBLE STRANDED DNA BREAK; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS REACTIVATION; VIRUS REPLICATION; WESTERN BLOTTING; CELL LINE; DNA REPAIR; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIRUS ACTIVATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CALCIUM-BINDING PROTEINS; CELL CYCLE; CELL LINE; DNA DAMAGE; DNA REPAIR; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 84930960536     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7062752     Document Type: Article

References (47)

1. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in aids-associated kaposi’s sarcoma. Science 1994, 266, 1865–1869.
2. Cesarman, E.; Chang, Y.; Moore, P.S.; Said, J.W.; Knowles, D.M. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in aids-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332, 1186–1191.
3. Soulier, J.; Grollet, L.; Oksenhendler, E.; Cacoub, P.; Cazals-Hatem, D.; Babinet, P.; D’Agay, M.F.; Clauvel, J.P.; Raphael, M.; Degos, L.; et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric castleman’s disease. Blood 1995, 86, 1276–1280.
4. Sun, R.; Lin, S.F.; Gradoville, L.; Yuan, Y.; Zhu, F.; Miller, G. A viral gene that activates lytic cycle expression of kaposi’s sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 1998, 95, 10866–10871.
5. Guito, J.; Lukac, D.M. Kshv reactivation and novel implications of protein isomerization on lytic switch control. Viruses 2015, 7, 72–109.
6. Martin, D.F.; Kuppermann, B.D.; Wolitz, R.A.; Palestine, A.G.; Li, H.; Robinson, C.A. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche ganciclovir study group. N. Engl. J. Med. 1999, 340, 1063–1070.
7. Grundhoff, A.; Ganem, D. Inefficient establishment of kshv latency suggests an additional role for continued lytic replication in kaposi sarcoma pathogenesis. J. Clin. Investig. 2004, 113, 124–136.
8. Rothkamm, K.; Kruger, I.; Thompson, L.H.; Lobrich, M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell. Biol. 2003, 23, 5706–5715.
9. Lieber, M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79, 181–211.
10. Ashley, A.K.; Shrivastav, M.; Nie, J.; Amerin, C.; Troksa, K.; Glanzer, J.G.; Liu, S.; Opiyo, S.O.; Dimitrova, D.D.; Le, P.; et al. DNA-pk phosphorylation of rpa32 ser4/ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe. DNA Repair Amst. 2014, 21, 131–139.
11. Zou, L.; Elledge, S.J. Sensing DNA damage through atrip recognition of rpa-ssdna complexes. Science 2003, 300, 1542–1548.
12. Chini, C.C.; Chen, J. Human claspin is required for replication checkpoint control. J. Biol. Chem. 2003, 278, 30057–30062.
13. Kumagai, A.; Lee, J.; Yoo, H.Y.; Dunphy, W.G. Topbp1 activates the atr-atrip complex. Cell 2006, 124, 943–955.
14. Singh, V.V.; Dutta, D.; Ansari, M.A.; Dutta, S.; Chandran, B. Kaposi’s sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment. J. Virol. 2014, 88, 2821–2834.
15. Xiao, Y.; Chen, J.; Liao, Q.; Wu, Y.; Peng, C.; Chen, X. Lytic infection of kaposi’s sarcoma-associated herpesvirus induces DNA double-strand breaks and impairs non-homologous end joining. J. Gen. Virol. 2013, 94, 1870–1875.
16. Jackson, B.R.; Noerenberg, M.; Whitehouse, A. A novel mechanism inducing genome instability in kaposi’s sarcoma-associated herpesvirus infected cells. PLoS Pathog. 2014, 10, e1004098.
17. Meerbrey, K.L.; Hu, G.; Kessler, J.D.; Roarty, K.; Li, M.Z.; Herschkowitz, J.I.; Burrows, A.E.; Fang, J.E.; Ciccia, A.; Sun, T.; et al. The pinducer lentiviral toolkit for inducible rna interference in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2011, 108, 3665–3670.
18. Vieira, J.; O’Hearn, P.M. Use of the red fluorescent protein as a marker of kaposi’s sarcoma-associated herpesvirus lytic gene expression. Virology 2004, 325, 225–240.
19. Nakamura, H.; Lu, M.; Gwack, Y.; Souvlis, J.; Zeichner, S.L.; Jung, J.U. Global changes in kaposi’s sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible rta transactivator. J. Virol. 2003, 77, 4205–4220.
20. Matthews, T.; Boehme, R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 1988, 10, S490–S494.
21. Bresnahan, W.A.; Boldogh, I.; Thompson, E.A.; Albrecht, T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late g1. Virology 1996, 224, 150–160.
22. Polo, S.E.; Jackson, S.P. Dynamics of DNA damage response proteins at DNA breaks: A focus on protein modifications. Genes Dev. 2011, 25, 409–433.
23. Kudoh, A.; Iwahori, S.; Sato, Y.; Nakayama, S.; Isomura, H.; Murata, T.; Tsurumi, T. Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in epstein-barr virus replication compartments. J. Virol. 2009, 83, 6641–6651.
24. Luo, M.H.; Rosenke, K.; Czornak, K.; Fortunato, E.A. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 2007, 81, 1934–1950.
25. Mohni, K.N.; Dee, A.R.; Smith, S.; Schumacher, A.J.; Weller, S.K. Efficient herpes simplex virus 1 replication requires cellular atr pathway proteins. J. Virol. 2013, 87, 531–542.
26. Wang, Y.; Li, H.; Tang, Q.; Maul, G.G.; Yuan, Y. Kaposi’s sarcoma-associated herpesvirus ori-lyt-dependent DNA replication: Involvement of host cellular factors. J. Virol. 2008, 82, 2867–2882.
27. Anderson, L.; Henderson, C.; Adachi, Y. Phosphorylation and rapid relocalization of 53bp1 to nuclear foci upon DNA damage. Mol. Cell. Biol. 2001, 21, 1719–1729.
28. Li, R.; Zhu, J.; Xie, Z.; Liao, G.; Liu, J.; Chen, M.R.; Hu, S.; Woodard, C.; Lin, J.; Taverna, S.D.; et al. Conserved herpesvirus kinases target the DNA damage response pathway and tip60 histone acetyltransferase to promote virus replication. Cell Host Microbe 2011, 10, 390–400.
29. Hagemeier, S.R.; Barlow, E.A.; Meng, Q.; Kenney, S.C. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. J. Virol. 2012, 86, 13360–13370.
30. Hau, P.M.; Deng, W.; Jia, L.; Yang, J.; Tsurumi, T.; Chiang, A.K.; Huen, M.S.; Tsao, S.W. Role of atm in the formation of the replication compartment during lytic replication of epstein-barr virus in nasopharyngeal epithelial cells. J. Virol. 2015, 89, 652–668.
31. Liu, S.; Bekker-Jensen, S.; Mailand, N.; Lukas, C.; Bartek, J.; Lukas, J. Claspin operates downstream of TOPBP1 to direct atr signaling towards chk1 activation. Mol. Cell. Biol. 2006, 26, 6056–6064.
32. Liu, S.; Opiyo, S.O.; Manthey, K.; Glanzer, J.G.; Ashley, A.K.; Amerin, C.; Troksa, K.; Shrivastav, M.; Nickoloff, J.A.; Oakley, G.G. Distinct roles for DNA-pk, atm and atr in rpa phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Res. 2012, 40, 10780–10794.
33. Cimprich, K.A.; Cortez, D. ATR: An essential regulator of genome integrity. Nat. Rev. Mol. Cell. Biol. 2008, 9, 616–627.
34. Jazayeri, A.; Falck, J.; Lukas, C.; Bartek, J.; Smith, G.C.; Lukas, J.; Jackson, S.P. ATM- and cell cycle-dependent regulation of atr in response to DNA double-strand breaks. Nat. Cell Biol. 2006, 8, 37–45.
35. 2 /M checkpoint arrest. Mol. Cell. Biol. 2010, 30, 3371–3383.
36. Rodriguez, A.; Jung, E.J.; Flemington, E.K. Cell cycle analysis of epstein-barr virus-infected cells following treatment with lytic cycle-inducing agents. J. Virol. 2001, 75, 4482–4489.
37. Wu, F.Y.; Tang, Q.Q.; Chen, H.; ApRhys, C.; Farrell, C.; Chen, J.; Fujimuro, M.; Lane, M.D.; Hayward, G.S. Lytic replication-associated protein (RAP) encoded by kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through ccaat/enhancer-binding protein-alpha. Proc. Natl. Acad. Sci. USA 2002, 99, 10683–10688.
38. Izumiya, Y.; Lin, S.F.; Ellison, T.J.; Levy, A.M.; Mayeur, G.L.; Izumiya, C.; Kung, H.J. Cell cycle regulation by kaposi’s sarcoma-associated herpesvirus k-bzip: Direct interaction with cyclin-CDK2 and induction of G1 growth arrest. J. Virol. 2003, 77, 9652–9661.
39. Kumar, P.; Wood, C. Kaposi’s sarcoma-associated herpesvirus transactivator rta induces cell cycle arrest in G0/G1 phase by stabilizing and promoting nuclear localization of p27kip. J. Virol. 2013, 87, 13226–13238.
40. Jarviluoma, A.; Koopal, S.; Rasanen, S.; Makela, T.P.; Ojala, P.M. Kshv viral cyclin binds to p27kip1 in primary effusion lymphomas. Blood 2004, 104, 3349–3354.
41. Arias, C.; Weisburd, B.; Stern-Ginossar, N.; Mercier, A.; Madrid, A.S.; Bellare, P.; Holdorf, M.; Weissman, J.S.; Ganem, D. Kshv 2.0: A comprehensive annotation of the kaposi’s sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog. 2014, 10, e1003847.
42. Koopal, S.; Furuhjelm, J.H.; Jarviluoma, A.; Jaamaa, S.; Pyakurel, P.; Pussinen, C.; Wirzenius, M.; Biberfeld, P.; Alitalo, K.; Laiho, M.; et al. Viral oncogene-induced DNA damage response is activated in kaposi sarcoma tumorigenesis. PLoS Pathog. 2007, 3, 1348–1360.
43. Bryan, B.A.; Dyson, O.F.; Akula, S.M. Identifying cellular genes crucial for the reactivation of kaposi’s sarcoma-associated herpesvirus latency. J. Gen. Virol. 2006, 87, 519–529.
44. Ward, I.M.; Chen, J. Histone H2AX is phosphorylated in an atr-dependent manner in response to replicational stress. J. Biol. Chem. 2001, 276, 47759–47762.
45. Fernandez-Capetillo, O.; Chen, H.T.; Celeste, A.; Ward, I.; Romanienko, P.J.; Morales, J.C.; Naka, K.; Xia, Z.; Camerini-Otero, R.D.; Motoyama, N.; et al. DNA damage-induced g2-m checkpoint activation by histone h2ax and 53bp1. Nat. Cell Biol. 2002, 4, 993–997.
46. Bailey, S.G.; Verrall, E.; Schelcher, C.; Rhie, A.; Doherty, A.J.; Sinclair, A.J. Functional interaction between epstein-barr virus replication protein zta and host DNA damage response protein 53bp1. J. Virol. 2009, 83, 11116–11122.
47. Lilley, C.E.; Chaurushiya, M.S.; Boutell, C.; Everett, R.D.; Weitzman, M.D. The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog. 2011, 7, e1002084.